Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors
Clinical trial NCT04678921 · COMPLETED
Trial details
- NCT number
- NCT04678921
- Sponsor
- I-Mab Biopharma US Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-17
- Primary completion
- 2022-11-21
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.